Geetanjali Ayurvedic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 8 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 20.89%
(FY 2020)
- Profit -69.06%
(FY 2020)
- Ebitda -1019.52%
(FY 2020)
- Net Worth 2.63%
(FY 2020)
- Total Assets 81.47%
(FY 2020)
About Geetanjali Ayurvedic
The Corporate was formerly known as Geetanjali Avurvedic Private Limited. The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sarvesh Gupta and Geeta Gupta serve as directors at the Company.
- CIN/LLPIN
U24304DL2016PTC309487
- Company No.
309487
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2016
- Date of AGM
05 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Geetanjali Ayurvedic Private Limited offer?
Geetanjali Ayurvedic Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic,Herbal Products & Medicine, Herbal Oil, Ayurvedic & Herbal Health Supplement, Herbal Juice, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Digestive System Drugs & Medicines, Digestive Drugs.
Who are the key members and board of directors at Geetanjali Ayurvedic?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geeta Gupta  | Director | 20-Dec-2016 | Current |
| Sarvesh Gupta | Director | 20-Dec-2016 | Current |
Financial Performance of Geetanjali Ayurvedic.
Geetanjali Ayurvedic Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 20.89% increase. The company also saw a substantial fall in profitability, with a 69.06% decrease in profit. The company's net worth moved up by a moderate rise of 2.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Geetanjali Ayurvedic?
In 2018, Geetanjali Ayurvedic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Geetanjali Ayurvedic?
Unlock and access historical data on people associated with Geetanjali Ayurvedic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Geetanjali Ayurvedic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geetanjali Ayurvedic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
